Skip to content

Clinical trials

Phase 2 Neoplasms trials in Thailand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2 Country / region: Thailand Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20101
20141
20171
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
AstraZeneca1
GlaxoSmithKline1
Mahidol University1
Merck KGaA, Darmstadt, Germany1
National Hospital Organization Nagoya Medical Center1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms8
Neoplasm Metastasis2
Breast Neoplasms1
Down Syndrome1
Melanoma1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1
Recurrence1
Skin Neoplasms1
Uterine Cervical Neoplasms1
Vomiting1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.